Cargando…

Ciliated muconodular papillary tumor masked by COVID-19 infection and aspergilloma

Novel coronavirus disease-2019 (COVID-19) continues to pose a threat all over the world with the effect of new variants. The frequency of other secondary infections such as aspergilloma in patients with COVID-19 disease is not uncommon. Extremely rare lesions such as ciliated muconodular papillary t...

Descripción completa

Detalles Bibliográficos
Autores principales: Coşgun, Tuğba, Zeren, Handan, Kocatürk, Celalettin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bayçınar Medical Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801477/
https://www.ncbi.nlm.nih.gov/pubmed/36605328
http://dx.doi.org/10.5606/tgkdc.dergisi.2022.22603
Descripción
Sumario:Novel coronavirus disease-2019 (COVID-19) continues to pose a threat all over the world with the effect of new variants. The frequency of other secondary infections such as aspergilloma in patients with COVID-19 disease is not uncommon. Extremely rare lesions such as ciliated muconodular papillary tumor can be masked by radiological images caused by COVID-19 infection or secondary pathologies associated with it, leading to difficulties in diagnosis. Herein, we report a case in whom a diagnosis of aspergilloma and ciliated muconodular papillary tumor after six months of COVID-19 infection was made.